Filing Details
- Accession Number:
- 0001144204-13-036173
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-06-21 21:30:43
- Reporting Period:
- 2013-06-19
- Filing Date:
- 2013-06-21
- Accepted Time:
- 2013-06-21 21:30:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1270073 | Intercept Pharmaceuticals Inc | ICPT | Pharmaceutical Preparations (2834) | 223868459 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1353128 | Gayle Barbara Duncan | C/O Intercept Pharmaceuticals, Inc. 18 Desbrosses Street New York NY 10013 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-06-19 | 8,557 | $8.67 | 14,741 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-06-19 | 42,018 | $9.82 | 56,759 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-06-19 | 50,575 | $34.50 | 6,814 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Options to Purchase Common Stock | Disposition | 2013-06-19 | 8,557 | $0.00 | 8,557 | $8.67 |
| Common Stock | Options to Purchase Common Stock | Disposition | 2013-06-19 | 42,018 | $0.00 | 42,018 | $9.82 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 8,940 | 2020-08-16 | No | 4 | M | Direct | |
| 44,520 | 2019-05-18 | No | 4 | M | Direct |
Footnotes
- The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 20, 2013.
- 2.0833% of shares originally underlying the option vest on a monthly basis through December 31, 2013, subject to the terms and conditions of the award and the Issuer's 2003 Stock Incentive Plan.
- All shares underlying this option have fully vested.
Billionaire Hedge Funds
